Marc Rosen, MD
Research & Publications
Biography
News
Locations
Research Summary
Our group develops, tests, and disseminates behavioral therapies for people with psychiatric and/or substance abuse disorders. We are working primarily with:
- People receiving disability payments related to their disorders;
- Veterans applying for Compensation and Pension
- People living with HIV
Extensive Research Description
We develop and test the efficacy of behavioral interventions for clients with comorbid psychiatric and substance abuse.
One line of research considers whether interventions targeting spending decisions by dually diagnosed clients might reduce their substance use. This question has been approached with surveys, analysis of data from quasi-experimental designs, and clinical trials. Our research has demonstrated that a high proportion of VA inpatients need money management assistance, and that expenditures for illicit drugs are not increased after benefits have been awarded. In several surveys, we have described generally high client ratings of satisfaction with a variety of involuntary payee arrangements.
In clinical trials, we have tested the efficacy of a money management-based intervention called ATM (Advisor Teller Money Manager). ATM involves a positive conception of the power of money to help clients achieve their goals and their ability to learn to manage their own affairs, as well as dampening the temptation to spend loose cash on illicit drugs and alcohol. In a recently-completed 36-week clinical trial of ATM, ATM participants had less cocaine use, reduced preference for immediate rewards (as measured by the Delayed Discounting Questionnaire), and greater likelihood of being assigned a payee compared to participants assigned to the Control intervention.
A second line of research considers interventions targeting medication non-adherence. A difficulty in counseling clients concerning the need to take prescribed medication is the difficulty in knowing when the medications were taken. In a series of studies, our group has tested the efficacy of counseling in which clients are provided electronically-generated feedback and review the dates and times medications were taken as prescribed and when they were missed. In clinical trials, we have found this counseling to be effective among clients prescribed medication for diabetes but ineffective among clients prescribed antiretroviral medication. However, review of feedback has been effective when coupled with material reinforcement, contingent on on-time bottle openings.
A third line of research examines the processes involved in applying for Compensation and Pension examinations. One multi-site study involves comparing a semi-structured method of conducting the Compensation and Pension evaluation of veterans being evaluated for PTSD to assessment as usual. A second study is comparing the effect of four sessions of Benefits Counseling to a control condition on engagement in work among veterans presenting for evaluation of psychiatric disabilities.
- Clinical trial of abstinence-linked money management in people with comorbid psychiatric disorders and cocaine use.
- Clinical trial of benefits counseling for veterans presenting for Compensation and Pension evaluations.
- E3 study comparing two methods of conducting Compensation and Pension evaluations of veterans presenting for psychiatric evaluations.
- Multisite Adherence evaluation of pooled data concerning adherence, viral loads and substance use among people with HIV
Coauthors
Research Interests
Mental Disorders; Psychopharmacology; Psychotherapy; Substance-Related Disorders; Psychiatry and Psychology
Selected Publications
- Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor AdherenceWang Y, Daar E, Huang Y, Xiong D, Shen J, Zhou L, Siqueiros L, Guerrero M, Rosen M, Liu H. Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence AIDS And Behavior 2023, 1-11. PMID: 37401993, DOI: 10.1007/s10461-023-04118-9.
- Compensation and Pension Exams for Military Sexual Trauma–Related Posttraumatic Stress Disorder: Examiner Perspectives, Clinical Impacts on Veterans, and StrategiesWebermann A, Nester M, Gianoli M, Black A, Rosen M, Mattocks K, Portnoy G. Compensation and Pension Exams for Military Sexual Trauma–Related Posttraumatic Stress Disorder: Examiner Perspectives, Clinical Impacts on Veterans, and Strategies Women's Health Issues 2023 PMID: 37003918, DOI: 10.1016/j.whi.2023.02.002.
- Proposed Changes to the Department of Veterans Affairs Disability Rating Rubric for Mental DisordersGianoli M, Meisler A, Rosen M. Proposed Changes to the Department of Veterans Affairs Disability Rating Rubric for Mental Disorders Psychiatric Services 2022, 74: 628-635. PMID: 36510762, DOI: 10.1176/appi.ps.20220377.
- Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trialLiu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage G, Guerrero M, Corado K, Rosen M, Fletcher C, Daar E. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial EBioMedicine 2022, 86: 104330. PMID: 36372731, PMCID: PMC9782816, DOI: 10.1016/j.ebiom.2022.104330.
- Optimizing the Impact of Pragmatic Clinical Trials for Veteran and Military Populations: Lessons From the Pain Management CollaboratoryAli J, Antonelli M, Bastian L, Becker W, Brandt CA, Burgess DJ, Burns A, Cohen SP, Davis AF, Dearth CL, Dziura J, Edwards R, Erdos J, Farrokhi S, Fritz J, Geda M, George SZ, Goertz C, Goodie J, Hastings SN, Heapy A, Ilfeld BM, Katsovich L, Kerns RD, Kyriakides TC, Lee A, Long CR, Luther SL, Martino S, Matheny ME, McGeary D, Midboe A, Pasquina P, Peduzzi P, Raffanello M, Rhon D, Rosen M, Esposito ER, Scarton D, Hastings SN, Seal K, Silliker N, Taylor S, Taylor SL, Tsui M, Wright FS, Zeliadt S. Optimizing the Impact of Pragmatic Clinical Trials for Veteran and Military Populations: Lessons From the Pain Management Collaboratory Military Medicine 2021, 187: 179-185. PMID: 34791412, PMCID: PMC9389906, DOI: 10.1093/milmed/usab458.
- Veterans’ compensation claims beliefs predict timing of PTSD treatment use relative to compensation and pension examBlack AC, Meshberg-Cohen S, Perez-Ortiz AC, Thornhill TA, Rosen MI. Veterans’ compensation claims beliefs predict timing of PTSD treatment use relative to compensation and pension exam PLOS ONE 2018, 13: e0209488. PMID: 30589882, PMCID: PMC6307722, DOI: 10.1371/journal.pone.0209488.
- Tailoring and testing an event history calendar of lifetime sexual partnerships for military VeteransBlack A, McMahon T, Brecht M, Rosen M. Tailoring and testing an event history calendar of lifetime sexual partnerships for military Veterans Military Psychology 2018, 30: 415-429. DOI: 10.1080/08995605.2018.1478560.
- Brief Counseling for Veterans with Musculoskeletal Disorder, Risky Substance Use, and Service Connection Claims.Rosen MI, Becker WC, Black AC, Martino S, Edens EL, Kerns RD. Brief Counseling for Veterans with Musculoskeletal Disorder, Risky Substance Use, and Service Connection Claims. Pain Medicine 2018, 20: 528-542. PMID: 29800338, PMCID: PMC6387983, DOI: 10.1093/pm/pny071.
- Impulsivity interacts with momentary PTSD symptom worsening to predict alcohol use in male veteransBlack AC, Cooney NL, Sartor CE, Arias AJ, Rosen MI. Impulsivity interacts with momentary PTSD symptom worsening to predict alcohol use in male veterans The American Journal Of Drug And Alcohol Abuse 2018, 44: 524-531. PMID: 29641264, PMCID: PMC6172135, DOI: 10.1080/00952990.2018.1454935.
- Financial Capability: Clinicians' Assessment of Beneficiaries With Dual DiagnosesThornhill T, Black AC, Rosen MI. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses Journal Of Dual Diagnosis 2018, 14: 130-136. PMID: 29505348, PMCID: PMC6291373, DOI: 10.1080/15504263.2018.1436732.
- Screening homeless Veterans for a voluntary money management skills training programIheanacho T, Ablondi K, Stefanovics E, Rosen M, Rosenheck R. Screening homeless Veterans for a voluntary money management skills training program American Journal Of Psychiatric Rehabilitation 2017, 20: 369-380. DOI: 10.1080/15487768.2017.1408504.
- Using a lifetime relationships calendar with veterans to model the effects of military deployment on sexual partneringRosen M, Black A, McMahon T, Brecht L, Potenza M. Using a lifetime relationships calendar with veterans to model the effects of military deployment on sexual partnering Drug And Alcohol Dependence 2017, 171: e178-e179. DOI: 10.1016/j.drugalcdep.2016.08.490.
- Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General RecommendationsSantana T, Greenwald M, Rosen M. Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General Recommendations Journal Of Addiction Research & Therapy 2017, 8: 1-8. DOI: 10.4172/2155-6105.1000315.
- Risky sexual behavior among OEF/OIF veterans with and without recent substance useRosen M, Black A. Risky sexual behavior among OEF/OIF veterans with and without recent substance use Drug And Alcohol Dependence 2015, 156: e192-e193. DOI: 10.1016/j.drugalcdep.2015.07.518.
- FISCAL: An all-data approach to assessing financial capability in people with psychiatric disabilities and substance useRosen M, Black A, Lazar C. FISCAL: An all-data approach to assessing financial capability in people with psychiatric disabilities and substance use Drug And Alcohol Dependence 2015, 146: e83. DOI: 10.1016/j.drugalcdep.2014.09.595.
- Work Outcomes After Benefits Counseling Among Veterans Applying for Service Connection for a Psychiatric ConditionRosen MI, Ablondi K, Black AC, Mueller L, Serowik KL, Martino S, Mobo BH, Rosenheck RA. Work Outcomes After Benefits Counseling Among Veterans Applying for Service Connection for a Psychiatric Condition Psychiatric Services 2014, 65: 1426-1432. PMID: 25082304, PMCID: PMC4713007, DOI: 10.1176/appi.ps.201300478.
- Developing a benefits counseling website for Veterans using Motivational Interviewing techniquesSerowik K, Ablondi K, Black A, Rosen M. Developing a benefits counseling website for Veterans using Motivational Interviewing techniques Computers In Human Behavior 2014, 37: 26-30. DOI: 10.1016/j.chb.2014.03.019.
- Financial capability: Standardizing assessment for adult beneficiaries with co-occurring disordersBlack A, McMahon T, Rosenheck R, Rosen M. Financial capability: Standardizing assessment for adult beneficiaries with co-occurring disorders Drug And Alcohol Dependence 2014, 140: e15. DOI: 10.1016/j.drugalcdep.2014.02.062.
- Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, Golin CE, Bangsberg DR, Liu H. Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14 AIDS And Behavior 2012, 17: 142-147. PMID: 22246513, PMCID: PMC3549004, DOI: 10.1007/s10461-011-0124-7.
- The ‘check effect’ reconsideredRosen MI. The ‘check effect’ reconsidered Addiction 2011, 106: 1071-1077. PMID: 21338431, PMCID: PMC3094507, DOI: 10.1111/j.1360-0443.2011.03409.x.
- A randomized controlled trial of a money management-based substance use intervention.Rosen MI, Carroll KM, Stefanovics E, Rosenheck RA. A randomized controlled trial of a money management-based substance use intervention. Psychiatric Services 2009, 60: 498-504. PMID: 19339325, PMCID: PMC2831204, DOI: 10.1176/appi.ps.60.4.498.
- A Randomized Controlled Trial of a Money Management-Based Substance Use InterventionRosen M, Carroll K, Stefanovics E, Rosenheck R. A Randomized Controlled Trial of a Money Management-Based Substance Use Intervention Psychiatric Services 2009, 60: 498-504. DOI: 10.1176/ps.2009.60.4.498.
- Effects of Illicit Drug Use on Adherence to Prescribed Antiretroviral MedicationRosen M, Rigsby M, Dieckhaus K, Cramer J. Effects of Illicit Drug Use on Adherence to Prescribed Antiretroviral Medication American Journal On Addictions 2003, 12: 455-458. DOI: 10.1080/10550490390240828.
- Motivational Enhancement and MEMS Review to Improve Medication AdherenceRosen M, Ryan C, Rigsby M. Motivational Enhancement and MEMS Review to Improve Medication Adherence Behaviour Change 2002, 19: 183-190. DOI: 10.1375/bech.19.4.183.
- Consumer Experience with Payeeship Provided by a Community Mental Health CenterRosen M, Desai R, Bailey M, Davidson L, Rosenheck R. Consumer Experience with Payeeship Provided by a Community Mental Health Center Psychiatric Rehabilitation Journal 2001, 25: 190-195. PMID: 11769986, DOI: 10.1037/h0095025.
- Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence InterventionRigsby M, Rosen M, Beauvais J, Cramer J, Rainey P, O'Malley S, Dieckhaus K, Rounsaville B. Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention Journal Of General Internal Medicine 2000, 15: 841-847. PMID: 11119180, PMCID: PMC1495713, DOI: 10.1046/j.1525-1497.2000.00127.x.
- Significant interaction between clozapine and cocaine in cocaine addictsFarren C, Hameedi F, Rosen M, Woods S, Jatlow P, Kosten T. Significant interaction between clozapine and cocaine in cocaine addicts Drug And Alcohol Dependence 2000, 59: 153-163. PMID: 10891628, DOI: 10.1016/s0376-8716(99)00114-3.
- Effects of Lamotrigine on Behavioral and Cardiovascular Responses to Cocaine in Human SubjectsWinther L, Saleem R, McCance-Katz E, Rosen M, Hameedi F, Pearsall H, Jatlow P, Kosten T, Woods S. Effects of Lamotrigine on Behavioral and Cardiovascular Responses to Cocaine in Human Subjects The American Journal Of Drug And Alcohol Abuse 2000, 26: 47-59. PMID: 10718163, DOI: 10.1081/ada-100100590.
- Naloxone Challenge in Smokers: Preliminary Evidence of an Opioid Component in Nicotine DependenceKrishnan-Sarin S, Rosen M, O'Malley S. Naloxone Challenge in Smokers: Preliminary Evidence of an Opioid Component in Nicotine Dependence JAMA Psychiatry 1999, 56: 663-668. PMID: 10401515, DOI: 10.1001/archpsyc.56.7.663.
- The effects of naltrexone maintenance on the response to yohimbine in healthy volunteersRosen M, Kosten T, Kreek M. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers Biological Psychiatry 1999, 45: 1636-1645. PMID: 10376126, DOI: 10.1016/s0006-3223(98)00259-5.
- Interactions of Cocaine with Nimodipine: A Brief ReportKosten T, Woods S, Rosen M, Pearsall H. Interactions of Cocaine with Nimodipine: A Brief Report American Journal On Addictions 1999, 8: 77-81. PMID: 10189518, DOI: 10.1080/105504999306117.
- The effect of lamotrigine on naloxone-precipitated opiate withdrawalRosen M, Pearsall H, Kosten T. The effect of lamotrigine on naloxone-precipitated opiate withdrawal Drug And Alcohol Dependence 1998, 52: 173-176. PMID: 9800147, DOI: 10.1016/s0376-8716(98)00057-x.
- Hydromorphone–Naloxone Combinations in Opioid-Dependent Humans Under a Naloxone Novel-Response Discrimination ProcedureOliveto A, Rosen M, Kosten T, Hameedi F, Woods S, Kosten T. Hydromorphone–Naloxone Combinations in Opioid-Dependent Humans Under a Naloxone Novel-Response Discrimination Procedure Experimental And Clinical Psychopharmacology 1998, 6: 169-178. PMID: 9608349, DOI: 10.1037/1064-1297.6.2.169.
- Recurrent personal memories during intoxication reported by patients with alcoholismHOFFMAN R, ESPOSITO R, ROSEN M, ROCKHOLZ P. Recurrent personal memories during intoxication reported by patients with alcoholism Psychological Medicine 1997, 27: 1441-1446. PMID: 9403915, DOI: 10.1017/s0033291797005400.
- Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patientsRosen M, Pearsall H, Woods S, Kosten T. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients Journal Of Substance Abuse Treatment 1997, 14: 149-154. PMID: 9258859, DOI: 10.1016/s0740-5472(96)00157-2.
- Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide TKosten T, Rosen M, McMahon T, Bridge T, O'malley S, Pearsall R, O'connor P. Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T The American Journal Of Drug And Alcohol Abuse 1997, 23: 543-553. PMID: 9366972, DOI: 10.3109/00952999709016894.
- Dose Dependent Effects of Yohimbine on Methadone Maintained PatientsHameedi F, Woods S, Rosen M, Pearsall H, Kosten T. Dose Dependent Effects of Yohimbine on Methadone Maintained Patients The American Journal Of Drug And Alcohol Abuse 1997, 23: 327-333. PMID: 9143642, DOI: 10.3109/00952999709040950.
- Acute cocaine effects on absolute cerebral blood flowWallace E, Wisniewski G, Zubal G, vanDyck C, Pfau S, Smith E, Rosen M, Sullivan M, Woods S, Kosten T. Acute cocaine effects on absolute cerebral blood flow Psychopharmacology 1996, 128: 17-20. PMID: 8944401, DOI: 10.1007/s002130050104.
- A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawalRosen M, McMahon T, Woods S, Pearsall H, Kosten T. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal European Journal Of Pharmacology 1996, 307: 251-257. PMID: 8836612, DOI: 10.1016/0014-2999(96)00249-x.
- Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.Rosen M, McMahon T, Hameedi F, Pearsall H, Woods S, Kreek M, Kosten T. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. Journal Of Pharmacology And Experimental Therapeutics 1996, 276: 1128-35. PMID: 8786543.
- The Effect of Gamma-Hydroxybutyric Acid on Naloxone-Precipitated Opiate WithdrawalRosen M, Pearsall H, Woods S, Kosten T. The Effect of Gamma-Hydroxybutyric Acid on Naloxone-Precipitated Opiate Withdrawal Neuropsychopharmacology 1996, 14: 187-193. PMID: 8866702, DOI: 10.1016/0893-133x(95)00087-t.
- Gender differences in response to intranasal cocaine administration to humansKosten T, Kosten T, McDougle C, Hameedi F, McCance E, Rosen M, Oliveto A, Price L. Gender differences in response to intranasal cocaine administration to humans Biological Psychiatry 1996, 39: 147-148. PMID: 8717615, DOI: 10.1016/0006-3223(95)00386-x.
- The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine AntagonistKosten T, DeCaprio J, Rosen M. The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine Antagonist Neuropsychopharmacology 1995, 13: 323-333. PMID: 8747757, DOI: 10.1016/0893-133x(95)00065-l.
- Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humansHameedi F, Rosen M, McCance-Katz E, McMahon T, Price L, Jatlow P, Woods S, Kosten T. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans Biological Psychiatry 1995, 37: 560-563. PMID: 7619981, DOI: 10.1016/0006-3223(94)00361-6.
- Opiate Dependence and Withdrawal: Preliminary Assessment Using Single Photon Emission Computerized Tomography (SPECT)Krystal J, Woods S, Kosten T, Rosen M, Seibyl J, Van Dyck C, Price L, Zubal I, Hoffer P, Charney D. Opiate Dependence and Withdrawal: Preliminary Assessment Using Single Photon Emission Computerized Tomography (SPECT) The American Journal Of Drug And Alcohol Abuse 1995, 21: 47-63. PMID: 7762544, DOI: 10.3109/00952999509095229.
- Reliability of Sequential Naloxone Challenge TestsRosen M, McMahon T, Margolin A, Gill T, Woods S, Pearsall H, Kreek M, Kosten T. Reliability of Sequential Naloxone Challenge Tests The American Journal Of Drug And Alcohol Abuse 1995, 21: 453-467. PMID: 8561097, DOI: 10.3109/00952999509002710.
- Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.Oliveto A, Rosen M, Woods S, Kosten T. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. Journal Of Pharmacology And Experimental Therapeutics 1995, 272: 231-41. PMID: 7815337.
- SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphinevan Dyck C, Rosen M, Thomas H, McMahon T, Wallace E, O'Connor P, Sullivan M, Krystal J, Hoffer P, Woods S, Kosten T. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine Psychiatry Research 1994, 55: 181-191. PMID: 7701033, DOI: 10.1016/0925-4927(94)90013-2.
- Buprenorphine: duration of blockade of effects of intramuscular hydromorphoneRosen M, Wallace E, McMahon T, Pearsall H, Woods S, Price L, Kosten T. Buprenorphine: duration of blockade of effects of intramuscular hydromorphone Drug And Alcohol Dependence 1994, 35: 141-149. PMID: 7519977, DOI: 10.1016/0376-8716(94)90121-x.
- Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone‐Maintained PatientsRosen M, Pearsall H, Price L, McDougle C, Woods S, Kosten T. Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone‐Maintained Patients American Journal On Addictions 1993, 2: 165-168. DOI: 10.1111/j.1521-0391.1993.tb00217.x.
- Effects of Acute Buprenorphine on Responses to Intranasal Cocaine: A Pilot StudyRosen M, Pearsall H, McDougle C, Price L, Woods S, Kosten T. Effects of Acute Buprenorphine on Responses to Intranasal Cocaine: A Pilot Study The American Journal Of Drug And Alcohol Abuse 1993, 19: 451-464. PMID: 8273766, DOI: 10.3109/00952999309001634.
- Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone-Maintained PatientsRosen M, Pearsall H, Price L, McDougle C, Woods S, Kosten T. Carbamazepine vs. Oxazepam for Benzodiazepine Detoxification in Methadone-Maintained Patients American Journal On Addictions 1993, 2: 165-168. DOI: 10.3109/10550499309115956.
- Use of cocaine to prevent opiate withdrawalRosen M, Wallace E, Sullivan M, Stine S, Kosten T. Use of cocaine to prevent opiate withdrawal American Journal Of Psychiatry 1992, 149: 1609b-1609. PMID: 1415835, DOI: 10.1176/ajp.149.11.1609b.
- Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug UsersRosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett‐Smith H, Thomas H, Van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV‐Positive Intravenous Drug Users American Journal On Addictions 1992, 1: 332-338. DOI: 10.1111/j.1521-0391.1992.tb00359.x.
- Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug UsersRosen M, Bridge T, O'Malley S, Pearsall H, Martini B, O'Connor P, Brett-Smith H, Thomas H, van Dyck C, Woods S, Kosten T. Peptide T Treatment of Cognitive Impairment in HIV-Positive Intravenous Drug Users American Journal On Addictions 1992, 1: 332-338. DOI: 10.3109/10550499208993153.
- Cocaine-Associated Panic Attacks in Methadone-Maintained PatientsRosen M, Kosten T. Cocaine-Associated Panic Attacks in Methadone-Maintained Patients The American Journal Of Drug And Alcohol Abuse 1992, 18: 57-62. PMID: 1314016, DOI: 10.3109/00952999209001611.
- Buprenorphine for cocaine and opiate dependence.Kosten T, Rosen M, Schottenfeld R, Ziedonis D. Buprenorphine for cocaine and opiate dependence. Psychopharmacology Bulletin 1992, 28: 15-9. PMID: 1609037.
- Buprenorphine for Opioid and Cocaine DependenceRosen M, Kosten T. Buprenorphine for Opioid and Cocaine Dependence 1992, 137-147. DOI: 10.1007/978-1-4612-0359-9_7.
- A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.Jenkins S, Warfield N, Blaine J, Cornish J, Ling W, Rosen M, Urschel H, Wesson D, Ziedonis D. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharmacology Bulletin 1992, 28: 21-6. PMID: 1609038.
- Buprenorphine: Beyond Methadone?Rosen M, Kosten T. Buprenorphine: Beyond Methadone? Psychiatric Services 1991, 42: 347-349. PMID: 2050347, DOI: 10.1176/ps.42.4.347.
Clinical Trials
Conditions | Study Title |
---|---|
COVID-19 Inpatient; COVID-19 Outpatient; Mental Health & Behavioral Research; Pain Control | Engaging Veterans Seeking Service-Connection Payments in Pain Treatment (PragmaticSBIRT) |